Histopathology of BCG and thiotepa treated bladders
- 1 September 1986
- journal article
- research article
- Published by Springer Nature in Urological Research
- Vol. 14 (4) , 211-215
- https://doi.org/10.1007/bf00441116
Abstract
In an effort to characterize the pathophysiological differences between the modes of action of BCG and thiotepa in the treatment of superficial bladder cancer, normal female rats received weekly intravesical instillations of both agents. The animals were sacrificed and their bladders were examined pathologically to determine if there were histological differences between the cellular infiltrates found in the BCG and thiotepa treated bladders. Monomuclear cells, particularly T-cells, predominated in the BCG treated bladders whereas polymorphonucleated cells predominated in the thiotepa treated bladders suggesting that there may be an immune aspect to the former therapy. The presence of T-cells following BCG therapy suggests a T-cell mediated immune response.Keywords
This publication has 30 references indexed in Scilit:
- ANTIBODY-RESPONSES TO BACILLUS CALMETTE-GUERIN DURING IMMUNOTHERAPY IN BLADDER-CANCER PATIENTS1981
- Two subsets of rat T lymphocytes defined with monoclonal antibodiesEuropean Journal of Immunology, 1980
- Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: Differentiation antigens of rat lymphocytesCell, 1977
- Thymic and splenic changes following injection of living Brucella and BCG in the Guinea pigCancer Immunology, Immunotherapy, 1977
- Effector cells for antibody-dependent cell mediated cytotoxicityCellular Immunology, 1977
- Induction of “natural killer” cells by BCGNature, 1976
- Letter: Effect of BCG on haemopoietic stem cells.1975
- BCG and CancerNew England Journal of Medicine, 1974
- THE MODIFYING EFFECT OF BCG ON THE IMMUNOLOGICAL INDUCTION OF T CELLSThe Journal of Experimental Medicine, 1974
- B.C.G. VACCINATION AND LEUKÆMIA MORTALITYThe Lancet, 1970